[HTML][HTML] A review of heterogeneity in attention deficit/hyperactivity disorder (ADHD)

Y Luo, D Weibman, JM Halperin, X Li - Frontiers in human …, 2019 - frontiersin.org
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that affects
approximately 8%-12% of children worldwide. Throughout an individual's lifetime, ADHD …

Genetics of ADHD: what should the clinician know?

O Grimm, TM Kranz, A Reif - Current psychiatry reports, 2020 - Springer
Abstract Purpose of Review Attention deficit hyperactivity disorder (ADHD) shows high
heritability in formal genetic studies. In our review article, we provide an overview on …

[HTML][HTML] Genetics in the ADHD clinic: how can genetic testing support the current clinical practice?

L Balogh, AJ Pulay, JM Réthelyi - Frontiers in Psychology, 2022 - frontiersin.org
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder with a
childhood prevalence of 5%. In about two-thirds of the cases, ADHD symptoms persist into …

The course of attention-deficit/hyperactivity disorder through midlife

EH Grevet, CE Bandeira, ES Vitola… - European Archives of …, 2024 - Springer
The course of ADHD from childhood up to young adulthood has been characterized in
several studies. However, little is known about the course of symptoms into middle age and …

[HTML][HTML] Salience and hedonic experience as predictors of central stimulant treatment response in ADHD–A resting state fMRI study

J Rode, R Runnamo, P Thunberg, M Msghina - Journal of Psychiatric …, 2023 - Elsevier
Abstract Background Roughly 20–30% of patients with Attention-deficit/hyperactivity
disorder (ADHD) fail to respond to central stimulant (CS) medication. Genetic, neuroimaging …

Recent developments in the genetics of attention‐deficit hyperactivity disorder

O Grimm, S Kittel‐Schneider… - Psychiatry and clinical …, 2018 - Wiley Online Library
Attention‐deficit hyperactivity disorder (ADHD) is a developmental psychiatric disorder that
affects children and adults. ADHD is one of the psychiatric disorders with the strongest …

[HTML][HTML] Shared genetic susceptibilities for irritable bowel syndrome and depressive disorder in Chinese patients uncovered by pooled whole-exome sequencing

S Zhu, M He, Z Liu, Z Qin, Z Wang, L Duan - Journal of Advanced Research, 2020 - Elsevier
Irritable bowel syndrome (IBS) is the most prevalent functional gastrointestinal disorder
presenting a high comorbidity with depressive disorder (DD). Many studies have confirmed …

STX1A gene variations contribute to the susceptibility of children attention-deficit/hyperactivity disorder: a case–control association study

M Wang, X Gu, X Huang, Q Zhang, X Chen… - European archives of …, 2019 - Springer
It was presumed syntaxin-1A (STX1A) might relate to the pathophysiology of attention-
deficit/hyperactivity disorder (ADHD), but the results were inconsistent. The present study …

[HTML][HTML] The association between SYT1-rs2251214 and cocaine use disorder further supports its role in psychiatry

BS da Silva, RB Cupertino, JB Schuch… - Progress in Neuro …, 2019 - Elsevier
Synaptotagmin-1 is an essential regulator of synaptic vesicle exocytosis, and its encoding
gene (SYT1) is a genome and transcriptome-wide association hit in cognitive performance …

Integrative proteomics and pharmacogenomics analysis of methylphenidate treatment response

BS da Silva, DT Leffa, WO Beys-da-Silva… - Translational …, 2019 - nature.com
Transcriptomics and candidate gene/protein expression studies have indicated several
biological processes modulated by methylphenidate (MPH), widely used in attention …